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1. Introduction 
Yellow nail syndrome was defined in 1964 as a combination of slow growing, discoloured 
nails and edema (Samman & White, 1964). The rate of growth of finger nails was less than 
0.2 mm per week compared with the normal 0.5-1.2 mm per week. The nails were thickened 
and the cuticles were deficient. The color varied from pale yellow to slightly greenish. 
Onycholysis (separation of the nail from its bed) and shedding of one or more nails was 
mentioned. - Of the 13 patients with yellow nails 10 presented with edema, mainly in the 
ankles.  
Subsequently, several symptoms were described and included. Sinusitis was reported by 
Wells (Wells,1966), although clearly he did not recognize it as part of the syndrome. Chronic 
intermittent cough with sputum production was reported by Zerfas (Zerfas, 1966), and in 
combination with sinusitis and bronchitis by Dilley et al (Dilley et al.,1968). Hiller et al. (1972) 
emphasized that chronic cough was a persistent finding in all their patients. 
Pleural effusion in combination with lymphedema was reported in three patients by Emerson 
(Emerson,1966). The pleural fluid was clear, with a protein content of 4-9 mg/100 ml. The 
predominant cell was the lymphocyte. The effusion always re-accumulated after drainage. 
Pericardial effusion in addition to pleural effusions and lymphedema was reported by 
Wakasa et al. (1987). 
1.1 Symptom frequency in published papers 
In 78 papers listed in PubMed from 1964 to 2009 there were 185 patients diagnosed with 
yellow nail syndrome: 18 % with yellow nails only, 42 % together with lymphedema, 21 % 
together with pleural effusion, and 19 % with the complete triad yellow nails-lymphedema-
pleural effusion. Thus lymphedema was diagnosed totally in 61 %. Cough and sinusitis 
were diagnosed in 32 %. 
Among several authors reporting sinusitis, some mention radiography revealing mucoid 
thickening of one or more sinuses (Nakielna et al, 1976, Hassard et al,1984, Camilleri, 1990, 
Varney et al, 1994, Cebecci et al, 2009). Varney et al. — at a Nose Clinic in London — 
reported that 14 out of 17 patients with yellow nail syndrome suffered severe rhinosinusitis, 
which predated nail changes in four, coincided with yellow nails in six, and occurred later 
in the remaining seven patients.  
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Among my patients, sinusitis and cough were the most common symptoms (Berglund & 
Carlmark, 2011). Several patients spontaneously mention postnasal drip and a “strange 
cough” as a main feature, often starting half a year after a titanium implant or start of 
medication with drugs containing titanium dioxide. 
2. Etiology: Titanium and titanium dioxide 
Since 1997 I have seen 35 patients with one or more of the symptoms or signs mentioned 
above. Twenty-seven patients had titanium implants, whereas eight were exposed to 
titanium dioxide.  
Titanium in nail clippings or shed nails from the patients was analyzed by energy 
dispersive x-ray fluorescence (Forsell et al., 1997). It was present in the nails in 
concentrations varying between 1 and 170 µg/g, with a median level of 5 µg/g (Berglund 
& Carlmark, 2011). Shed nails had high levels (46, 41, 22 and 6 µg/g), but some nail 
clippings had even higher levels (170, 120 and 111 µg/g). Titanium levels do not seem to 
correlate with yellowness or thickness of nails. Titanium was not found in nails from 
healthy subjects, not even if exposed to titanium + gold (one subject) or to drugs with 
titanium dioxide. 
In two patients titanium was analyzed in separate nail clippings of the left hand. The 
thumbnail had higher level (5.6 and 4.1 µg/g) than the other nails (2.8 – 3.2 and 3.1 - 4.1  
µg/g, respectively). In two patients the levels in clippings from thumb and big toe were 
identical (1.7 µg/g) or nearly identical (1.7 versus 1.6 µg/g). In one patient the titanium level 
was 48 µg/g in a shed nail, but only 6.7 µg/g in fresh clippings. Nowadays I ask for 
clippings from the left thumbnail, except when shed nails are available. 
2.1 Titanium metal 
Titanium (Ti): atomic weight 47.9, atomic number 22, specific gravity 4.54. When pure, 
titanium is a lustrous, white metal. It is 60 % heavier than aluminum, but twice as strong. 
Titanium is a much harder metal than aluminum and approaches the high hardness 
possessed by some of the heat-treated steels, which causes some difficulties in dentistry. 
Its modulus of rigidity falls between that of aluminum and that of steel. The high 
ductility enables the use of titanium in cochlear implant electrodes.  Since it is non-
ferromagnetic, patients with titanium implants can be safely examined with magnetic 
resonance imaging.  
Titanium is quite sensitive to galvanic corrosion, e.g. by other metals and fluorine. This is to 
be expected when comparing their reduction potentials. 
2.2 Reduction potentials (Hunsburger, 1976) 
Our body shows high electrical conductivity. This enables our recording of the 
electrocardiogram through electrodes applied to the skin. The higher resistance in the 
skin is abolished by perspiration (hypotonic saline). The presence of metals with 
different reduction potentials may give rise to galvanic phenomena within the body or 
across the skin. (A young man with a gold ring in one ear experienced a buzzing 
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sensation in the ear while holding a coca-cola can for a while in his hand). Ions of 
different sorts can be introduced through the skin by means of electric current, so-called 
iontophoresis.  
Reaction Potential (Volts) 
Ti+2   + 2e− ⟺  Ti −1.63 
TiO2 + 4H+ + 4e− ⟺ Ti + 2H2O −0.86 
Ag+   +   e− ⟺  Ag +0.80 
Hg+2  + 2e− ⟺  Hg +0.85 
Au+   +   e− ⟺  Au +1.69 
F2      + 2e− ⟺  2F− +2.87 
2.3 Titanium implant patients 
My first patient got a titanium and a cobalt-chromium implant in her right knee. Half a year 
later she developed a persistent cough. Later her nails became thick and yellow, and a few 
nails were shed. She had gold in many of her teeth. Analysis for metals in nail clippings 
revealed high levels of titanium (Berglund & Carlmark, 2011). Three years later she had 
normal nails and no cough, but her knee implant had loosened. She got a new implant, and 
a year later she had her cough and yellow nails again. 
The dominant cause of yellow nail syndrome in my patients was the galvanic interaction 
between titanium implants and gold. There were 23 females and 4 males, aged 15-86 years at 
onset of symptoms. Most titanium implants were in the teeth (pins or crowns) or in the jaw 
bones, but also in the knees and hips, or in the abdomen (clips and staples) after 
laparoscopic surgery. In one patient there was iontophoresis of titanium ions from titanium 
spectacles to gold in the teeth.   
The gold electrodes were present mostly as dental inlays and crowns, but in two patients 
as wedding or engagement rings. Some patients reported intolerance to gold jewelry. 
Patch tests with gold cannot be done in titanium implant patients. In three patients 
amalgam, which contains silver and mercury, formed the electric circuit with titanium. I 
always advise patients with amalgam or titanium not to wear metal jewelry. In three 
patients the local application of fluoride gel caused release of titanium from titanium 
inlays in the teeth. In vitro, the oxidative release of titanium ions from titanium increases 
sharply in the presence of fluoride (Reclaru & Meyer, 1998, Strietzel et al., 1998, Schiff et 
al., 2002). 
Most patients with titanium implants suspected metal involvement and contacted me 
through the Swedish Society of Dental Amalgam Patients. However, in published papers 
most patients were probably exposed to titanium dioxide.   
2.4 Titanium dioxide: Uses and intestinal uptake 
Titanium dioxide, TiO2, is insoluble in water and acid but soluble in alkali. Because of its 
brightness and high refractive index it is the most widely used white pigment. Titanium 
dioxide is widely used in the food and drug industry as a whitening agent and is given the 
European food additive number E171. 
www.intechopen.com
 Novel Strategies in Lymphedema 
 
26
After oral administration of titanium dioxide to rats, particles of titanium dioxide were 
present in the gut associated lymphoid tissue, but also in  the liver, spleen, lungs and 
peritoneal tissues, but were not detected in the heart or the kidney (Jani et al., 1994).  
Titanium, together with aluminum, has consistently been found in lymphoid tissue of the 
ileum and in mesenteric lymph glands in patients with intestinal disease and in postmortem 
cases with no evidence of gastrointestinal disease (Shepherd et al., 1987). After 
administration of gelatin capsules with 23 mg titanium dioxide (mean particle size 0.16 µm) 
to five male subjects, blood levels of titanium rose from 12 µg/L to 43 µg/L at 4-12 hours 
(Böckmann et al., 2000).  The concentration/time curves were considered to be characteristic 
for a persorption mechanism (absorption in pores only slightly wider than the diameter of 
absorbed molecules). 
2.5 Titanium dioxide patients   
Several papers mention the exposure to drugs preceding the development of yellow nails 
and also return to normal conditions after withdrawal of the drugs (David-Vaudey et al., 
2004).  It turns out that that all the drug tablets mentioned contain titanium dioxide.  
I had eight patients (4 male, 4 female, age 15-79 years at onset of symptoms) exposed to 
titanium dioxide, six via drug tablets, one via confectionary, and one via chewing gum. 
Seven had more than ten amalgam restorations in their teeth and had gastrointestinal 
symptoms, mostly diarrhea, that may have facilitated the absorption of titanium dioxide. A 
lactulose test in one patient showed increased intestinal permeability. This might explain 
why relatively few patients develop the syndrome. Also, some patients told me that their 
strange cough started only after 6 months medication. Most patients don’t take their 
medicines (e.g. antibiotics) that long. 
3. Pathogenesis 
3.1 Nail changes 
Samman and White (1964) suggested that nail changes and defective lymph drainage are 
related. Emerson (1966) even considered that “nail changes are believed to be the result of 
defective lymph drainage”. Since titanium is always present in the nails of these patients, it 
is more tempting to consider the nail changes as a toxic reaction to titanium. 
3.2 Lymphedema, pleural effusions and ascites; defective lymph drainage or 
increased vascular leakage? 
Lymphangiograms, as performed in four patients with lymphedema in the legs, were 
interpreted as showing defective lymph drainage (Samman & White, 1964) Similar findings 
have been reported later (Müller et al., 1979). More recently Danielsson et al. (2006), using 
lymphoscintigraphy in a patient with edema, pleural effusions, hypoalbuminemia and 
yellow nails, found normal lymph flow and no signs of lymphatic obstruction in the lower 
extremities! 
Emerson (1966) noted high protein content (40-90 g/L) in pleural effusion, but still 
considered the primary event to be defective lymph drainage, which could not handle 
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increased lymph formation, e.g. after some infection. Protein-losing enteropathy in patients 
with pleural effusions, in some cases together with ascites, has also been reported (Duhra et 
al., 1985, Battaglia et al., 1985, Malek et al., 1996). In a patient with edema, plural effusion, 
hypoalbuminaemia and yellow nails, D’Allessandro et al. (2001)  found a 10-fold increase in 
normal albumin enteric loss. Since in most cases of yellow nail syndrome the pleural fluid 
has a very high protein content, this reflects increased protein permeability of systemic 
capillaries. D’Allessandro et al claimed that “the theory of pure lymphatic block is not 
sufficient to explain all the clinical manifestations of yellow nail syndrome”, and suggested 
that microangiopathy and increased microvascular filtration at different sites (pleura, liver, 
limbs, intestine) due to an alteration in the interstitial matrix, could play a role in addition to 
lymphatic abnormality. 
These reports indicate that increased vascular permeability rather than lymphatic 
abnormality is a key factor in yellow nail syndrome.  
3.3 Prenatal and neonatal manifestations   
There are two reports on pregnancy in women with yellow nails and bronchitis or 
productive cough (Govaert et al., 1992, Slee et al., 2000).  Ultrasonography demonstrated 
polyhydramnios and bilateral pleural effusion in the fetuses at 23 and 29 weeks of gestation, 
respectively.  At delivery both infants were hydropic and had bilateral pleural effusions, 
which were treated by thoracic drainage.  Following initial recovery, pleural effusion 
recurred 2 days after starting enteral feeding at 4 weeks of age in the first infant, but not in 
the second.  Our interpretation is that both mothers were exposed to titanium or titanium 
dioxide, and that titanium was transferred across the placenta, and possibly also via 
maternal milk. 
There are a few reports of familiar occurrence of yellow nail syndrome (Lambert et al., 2006). 
They might be explained by several family members consuming drugs or chewing gum 
containing titanium.  
4. Diagnosis  
Yellow discoloration of the nails is often a late sign of the  syndrome and therefore not 
necessary for the diagnosis of yellow nail syndrome; sinusitis and cough, lymphedema and 
pleural effusion occurring alone or in combination may represent the same syndrome 
(Varney et al., 1994, Cebecci et al., 2009). The diagnosis is supported by history or evidence 
of exposure to titanium implants or to titanium dioxide, and can be confirmed (if necessary) 
by the presence of titanium in nail clippings (>1 µg/g). 
5. Treatment 
5.1 Titanium implants 
Most often it is impossible or extremely difficult to remove titanium implants. It is usually 
much easier to remove the gold (in teeth, jewelry or rings). In a few patients gold removal 
(Berglund & Carlmark, 2011) has led to recovery after a period of several months. Because of 
the hardness of titanium, drilling of dental inlays should not be attempted! Even if removed, 
titanium may have migrated into gold inlays and will slowly be released over months or 
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years. I know of two instances where titanium inlays were successfully removed by the use 
of ultrasonic sound. 
Removal of dental amalgam fillings has as yet not been encouraging. Some mercury will 
remain in the surrounding dental tissue and in various organs in the body. Mercury enters 
the enterohepatic circulation, often maintaining diarrhea or constipation.  
Pleural effusions may require serial thoracocentesis. Pleurodesis relieves pleural effusion 
but may exacerbate lymphedema of the lower limbs (Kawano et al., 2003). In other patients a 
pleuroperitoneal (Brofman et al., 1990) or a pleurovenous shunt has been applied (Tanaka et 
al., 2005). 
5.2 Titanium dioxide 
Patients taking drugs containing titanium dioxide may have difficulties finding titanium-
free replacements. They may have to resort to fluid preparations designed for children, or 
have titanium-free capsules made. Almost all chewing gums contain titanium dioxide, but 
not Stimorol senses (except the one with peppermint taste). 
6. Summary 
Yellow nail syndrome was defined in 1964 to include thick yellow nails and lymphedema. A 
number of symptoms have later been included, most importantly perhaps sinusitis and 
chronic cough, because they are easily overlooked by the doctor. Most serious are pleural 
effusions and protein-losing enteritis. The syndrome is caused by titanium or titanium 
dioxide. 
7. Acknowledgement  
All costs for this study were defrayed by the Swedish Society of Dental Amalgam Patients, 
Trollhättan,Sweden. 
8. References 
Battaglia A, Di Ricco G, Mariani G & Giuntini C (1985). Pleural effusion and recurrent 
bronchopneumonia with lymphedema, yellow nails and protein losing 
enteropathy.  Eur J Respir Dis 66: 65-69. 
Berglund F & Carlmark B (2011). Titanium, sinusitis, and the yellow nail syndrome Biol 
Trace Elem Res 143:1-7. 
Böckmann J, Lahl H, Eckert T & Unterhalt B (2000). Titan-Blutspiegel vor und nach 
Belastungsversuchen mit Titandioxid. Pharmazie 55:140-143. 
Brofman JD, Hall JB, Scott W & Little AG (1990). Yellow nails, lymphedema and pleural 
effusion. Treatment of chronic pleural effusion with pleuroperitoneal shunting. 
97:743-5 
Camilleri AE (1990). Chronic sinusitis and the yellow nail syndrome. J Laryngol Otol 104:811–
813  
Cebeci F, Celebi M & Onsun N (2009). Nonclassical yellow nail syndrome in six-year-old 
girl: a case report. Cases J  2:165–169  
www.intechopen.com
 Titanium and Yellow Nail Syndrome 
 
29 
D’Allessandro A, Muzi G, Monaco A, Filiberto S, Barboni A & Abbritti G (2001). Yellow nail 
syndrome: does protein leakage play a role?  Eur Respir J 17: 149-152. 
Danielsson Å, Toth E & Thorlacius H (2006). Capsule endoscopy in the management of a 
patient with a rare syndrome. Gut 55: 196 
David-Vaudey E, Jamard B, Hermant C & Cantagrel A (2004). Yellow nail syndrome in 
rheumatoid arthritis: a drug-induced disease? Clin Rheumatol  23: 376-378.  
Dilley JJ, Kierland RR, Randall RV & Shick RM (1968). Primary lymphedema associated with 
yellow nails and pleural effusions. JAMA 204:122-125 
Duhra PM, Quigley EMM & Marsh MN (1985). Chylous ascites, intestinal 
lymphoangiectasia and the yellow nail syndrome. Gut 26:1266-1269 
Emerson PA (1966).  Yellow nails, lymphoedema, and pleural effusions. Thorax 21: 247-253. 
Forsell M, Marcusson JA, Carlmark B & Johansson O (1997).  Analysis of the metal content 
of in vivo fixed dental alloys by means of a simple office procedure. Swed Dent J 21: 
161-168 
Govaert P, Leroy JG, Pauwels R, Vanhaesebrouck P, De Praeter C, Van Kets H & Goeteyn M 
(1992). Perinatal manifestations of maternal yellow nail syndrome. Pediatrics 
89:1016-1018 
Hassard AD, Martin J & Ross JB (1984). Yellow nail syndrome and chronic sinusitis. J 
Otolaryngol 13:318–320  
Hiller E, Rosenow III EC & Olsen AM (1972). Pulmonary manifestations of the yellow nail 
syndrome. Chest 61:452-458.  
Hunsberger JF (1976). Electrochemical series Table I. In: Weast RC (ed) Handbook of chemistry 
and physics; 57th edn. CRC Press, Boca Raton, pp D141–D143  
Jani PU, McCarthy DE & Florence AT (1994). Titanium dioxide (rutile) particle uptake from 
the rat GI tract and translocation to systemic organs after oral administration. Int J 
Pharm 105: 157-168. 
Kawano T, Matsuse H, Shigematsu K, Miyazaki M, Taguchi T & Kohno S (2003). Chemical 
pleurodesis could exacerbate lymphedema of yellow nail syndrome. Acta Med 
Nagasaki 48:71-72 
Malek NP, Ocran K, Tietge UJ, Maschek H, Gratz KF, Trautwein C, Wagner S & Manns MP 
(1996). A case of the yellow nail syndrome associated with massive chylous ascites, 
pleural and pericardial effusions. Z Gastroenterol 34:763-766. 
Müller R-P, Peters PE, Echternacht-Happle K & Happle R (1979). Roentgenographic and 
clinical signs in yellow nail syndrome. Lymphology 12:257-261 
Nakielna EM, Wilson J & Ballon HS (1976). Yellow nail syndrome: report of three cases. Can 
Med Assoc J 115:46–48  
Reclaru L & Meyer J-M (1998). Effects of fluoride on titanium and other dental alloys in 
dentistry.  Biomaterials 19: 85-92 
Samman PD & White WF (1964). The “yellow nail” syndrome. Br J Dermatol  76:153-157 
Schiff N, Grosgogeat B, Lissac M & Dalard F (2002). Influence of fluoride content and pH on 
the corrosion resistance of titanium and its alloys. Biomaterials 23: 1995-2002   
Shepherd NA, Crocker PR, Smith AP & Levison DA (1987).  Exogenous pigment in Peyer's 
patches. Hum Pathol 18: 50-54. 
Slee J, Nelson J, Dickinson J, Kendall P & Halbert A (2000).  Yellow nail syndrome 
presenting as non-immune hydrops: Second case report.  Am J Med Genet 93:1-4  
www.intechopen.com
 Novel Strategies in Lymphedema 
 
30
Strietzel R, Hösch A, Kalbfleisch H, Buch D (1998). In vitro corrosion of titanium. 
Biomaterials 19: 1495-1499. 
Tanaka E, Matsumoto K, Shindo T & Taguchi Y (2005). Implantation of a pleurovenous 
shunt for massive chylothorax in a patient with yellow nail syndrome. Thorax 
60:254-255. 
Varney VA, Cumberworth V, Sudderick R, Durham SR & Mackay IS (1994). Rhinitis, 
sinusitis and the yellow nail syndrome: a review of symptoms and response to 
treatment in 17 patients. Clin Otolaryngol Allied Sci19:237–240  
Wakasa M, Imaizumi T, Suyama A, Takeshita A & Nakamura M (1987) Yellow nail 
syndrome associated with chronic pericardial effusion. Chest 92:366-7. 
Wells GC (1966). Yellow nail syndrome with familial primary hypoplasia of lymphatics, 
manifest late in life. Proc Royal Soc Med 59:447 
Zerfas  AJ (for HJ Wallace).  Yellow nail syndrome with bilateral bronchiectasis.  Proc Royal 
Soc Med 59: 448. 
www.intechopen.com
Novel Strategies in Lymphedema
Edited by Dr. Alberto Vannelli
ISBN 978-953-307-929-5
Hard cover, 108 pages
Publisher InTech
Published online 25, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Lymphedema is a swelling caused by the abnormal accumulation of lymphatic fluid in the skin. Lymphedema
can be caused by burns, injury, surgery, radiation therapy or cancer treatment that cancer survivors undergo.
Risk of developing lymphedema is high especially in those with breast or prostate cancer. It is hereditary and
can appear without warning at any time of life and is related to obesity and circulatory problems. If not treated,
lymphedema can be painful and lead to life-threatening infections. This book will help physicians who deal with
lymphedema. It will help you understand how the lymphatic system works, how lymphedema is diagnosed,
how to cope with the challenges of lymphedema, how to find treatment, and how to deal with insurance issues.
Novel Strategies in Lymphedema is for those with, or at risk of, developing lymphedema, and the healthcare
professionals who care for them.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Fredrik Berglund (2012). Titanium and Yellow Nail Syndrome, Novel Strategies in Lymphedema, Dr. Alberto
Vannelli (Ed.), ISBN: 978-953-307-929-5, InTech, Available from: http://www.intechopen.com/books/novel-
strategies-in-lymphedema/titanium-and-the-yellow-nail-syndrome
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
